Tomohiro Kubo

717 total citations
32 papers, 513 citations indexed

About

Tomohiro Kubo is a scholar working on Epidemiology, Oncology and Immunology. According to data from OpenAlex, Tomohiro Kubo has authored 32 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Oncology and 8 papers in Immunology. Recurrent topics in Tomohiro Kubo's work include Pancreatic and Hepatic Oncology Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Tomohiro Kubo is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Tomohiro Kubo collaborates with scholars based in Japan, United States and France. Tomohiro Kubo's co-authors include Hidekazu Nishimura, Koji Miyanishi, Masayoshi Kobune, Junji Kato, Yutaka Kawano, Shingo Tanaka, Tsutomu Sato, Yasushi Sato, Kohichi Takada and Toshifumi Hoki and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Hepatology.

In The Last Decade

Tomohiro Kubo

30 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomohiro Kubo Japan	12	163	152	115	110	80	32	513
Daniel Klintman Sweden	11	163 1.0×	138 0.9×	45 0.4×	75 0.7×	78 1.0×	16	428
Ravi Vats United States	10	131 0.8×	95 0.6×	129 1.1×	209 1.9×	64 0.8×	22	555
Leonidas A. Bourikas Greece	12	94 0.6×	101 0.7×	66 0.6×	58 0.5×	100 1.3×	29	503
G.C. Naccari Italy	5	268 1.6×	175 1.2×	30 0.3×	218 2.0×	144 1.8×	5	762
Jamie Robertson United Kingdom	5	155 1.0×	58 0.4×	76 0.7×	130 1.2×	73 0.9×	9	566
Yusuke Kawauchi Japan	12	177 1.1×	258 1.7×	20 0.2×	215 2.0×	102 1.3×	21	691
Ayako Mabuchi Japan	12	340 2.1×	71 0.5×	49 0.4×	122 1.1×	98 1.2×	31	579
Chenxuan Yang China	9	184 1.1×	105 0.7×	28 0.2×	248 2.3×	38 0.5×	21	496
CJ Hawkey United Kingdom	8	132 0.8×	199 1.3×	56 0.5×	67 0.6×	35 0.4×	30	752
Jaswinder Singh Maras India	15	66 0.4×	366 2.4×	57 0.5×	239 2.2×	44 0.6×	61	749

Countries citing papers authored by Tomohiro Kubo

Since Specialization

Citations

This map shows the geographic impact of Tomohiro Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Kubo more than expected).

Fields of papers citing papers by Tomohiro Kubo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Kubo. The network helps show where Tomohiro Kubo may publish in the future.

Co-authorship network of co-authors of Tomohiro Kubo

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Kubo. A scholar is included among the top collaborators of Tomohiro Kubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Kubo. Tomohiro Kubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arihara, Yohei, Ko Kobayashi, Shintaro Sugita, et al.. (2024). Marked Response to Nivolumab by a Patient With SMARCA4‐Deficient Undifferentiated Urothelial Carcinoma Showing High PD‐L1 Expression: A Case Report. Cancer Reports. 7(6). e2127–e2127.

Kubo, Tomohiro, Yohei Arihara, Makoto Yoshida, et al.. (2023). Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study. Japanese Journal of Clinical Oncology. 54(1). 47–53. 3 indexed citations

Ito, Ryo, Koji Miyanishi, Tomohiro Kubo, et al.. (2023). Synergistic antitumor effect of histone deacetylase class IIa inhibitor with lenvatinib in hepatocellular carcinoma. Hepatology International. 17(3). 735–744. 11 indexed citations

Osuga, Takahiro, Koji Miyanishi, Shingo Tanaka, et al.. (2023). Occurrence of Autoimmune Encephalitis in a Patient with Hepatocellular Carcinoma after Atezolizumab and Bevacizumab Combination Therapy: A Case Study. Kanzo. 64(11). 559–566. 1 indexed citations

Usami, Makoto, Kohichi Takada, Hajime Nakamura, et al.. (2022). Achievement of a durable response with eribulin for relapsed cardiac metastasis of uterine leiomyosarcoma after surgery: a case report and literature review. Annals of Palliative Medicine. 12(1). 205–211. 1 indexed citations

Kato, Toru, et al.. (2022). Two cases of resected gallbladder carcinosarcoma with a contrasting course. International Journal of Surgery Case Reports. 92(C). 106915–106915. 3 indexed citations

Sakamoto, Hiroki, Koji Miyanishi, Shingo Tanaka, et al.. (2021). MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model. Scientific Reports. 11(1). 3599–3599. 6 indexed citations

Nakamura, Hajime, Kohichi Takada, Naotaka Hayasaka, et al.. (2021). Six-transmembrane epithelial antigen of the prostate 1 accelerates cell proliferation by targeting c-Myc in liver cancer cells. Oncology Letters. 22(1). 546–546. 13 indexed citations

Ikeda, Yuki, Makoto Yoshida, Tomohiro Kubo, et al.. (2020). Pancreatic cancer with leptomeningeal carcinomatosis: case report and literature review. International Cancer Conference Journal. 9(2). 96–100. 5 indexed citations

10.

Ikeda, Yuki, Makoto Yoshida, Tomohiro Kubo, et al.. (2020). Rare case of acinar cell carcinoma with multiple lesions in the pancreas. JGH Open. 4(6). 1242–1243. 2 indexed citations

11.

Kubo, Tomohiro, Rizwan Romee, John Koreth, et al.. (2018). Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56bright NK Cells in Patients with Chronic Gvhd. Blood. 132(Supplement 1). 606–606. 3 indexed citations

12.

Kamihara, Yusuke, Édouard Forcade, John Koreth, et al.. (2018). Low-Dose Interleukin-2 Therapy Activates Circulating T Follicular Regulatory Cells (cTFR) and Suppresses Circulating T Follicular Helper Cells (cTFH) in Patients with Chronic Gvhd. Biology of Blood and Marrow Transplantation. 24(3). S72–S72. 4 indexed citations

13.

Kamihara, Yusuke, Édouard Forcade, John Koreth, et al.. (2017). Low-Dose Interleukin-2 Therapy Activates Circulating T Follicular Regulatory Cells and Suppresses Circulating T Follicular Helper Cells in Patients with Chronic Gvhd. Blood. 130(Suppl_1). 74–74. 2 indexed citations

14.

Kawano, Yutaka, Koji Miyanishi, Satoshi Takahashi, et al.. (2017). Hepatitis C virus reactivation due to antiemetic steroid therapy during treatment of hepatocellular carcinoma. Journal of Infection and Chemotherapy. 23(5). 323–325. 5 indexed citations

15.

Kubo, Tomohiro, Yutaka Kawano, Nobuaki Himuro, et al.. (2015). BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer. Gastric Cancer. 19(3). 827–838. 21 indexed citations

16.

Tanaka, Shingo, Koji Miyanishi, Masayoshi Kobune, et al.. (2013). Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Journal of Gastroenterology. 48(11). 1249–1258. 80 indexed citations

17.

Kubo, Tomohiro, Yuko Watanabe, Masahiro Abe, et al.. (2009). Augmented TLR9-induced Btk activation in PIR-B–deficient B-1 cells provokes excessive autoantibody production and autoimmunity. The Journal of Experimental Medicine. 206(9). 1971–1982. 66 indexed citations

18.

Nakamura, Akira, Tomohiro Kubo, & Toshiyuki Takai. (2008). Fc Receptor Targeting in the Treatment of Allergy, Autoimmune Diseases and Cancer. Advances in experimental medicine and biology. 640. 220–233. 7 indexed citations

19.

Kubo, Tomohiro & Hidekazu Nishimura. (2006). Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children. Phytomedicine. 14(2-3). 96–101. 72 indexed citations

20.

Kubo, Tomohiro, Kengo Sato, Daisuke Kobayashi, et al.. (2006). A case of HHV-6 associated acute necrotizing encephalopathy with increase of CD56^brightNKcells. Scandinavian Journal of Infectious Diseases. 38(11-12). 1122–1125. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact